Inserm Company Profile

15:17 EST 14th December 2018 | BioPortfolio



101 rue de Tolbiac


Phone: 33 (0)1 44 23 60 00
Fax: 33 (0)1 45 85 68 56

News Articles [29 Associated News Articles listed on BioPortfolio]

Type 2 diabetes: A therapeutic avenue is emerging

(INSERM (Institut national de la santé et de la recherche médicale)) Restoring the action of insulin is one of the keys to fighting type 2 diabetes. Researchers from Inserm led by Dominique Langin ...

[Editorial] France may be back, but the old ways persist for INSERM

On June 12, the term of the Chief Executive Officer (CEO) of the French National Institute of Health and Medical Research (INSERM) ends. The office of the current CEO, Yves Lévy, came under heavy cri...

MON 810 and NK603 GM Maize: No effects detected on rat health or metabolism

(INSERM (Institut national de la santé et de la recherche médicale)) A diet based on MON 810 or NK603 transgenic maize does not affect the health or metabolism of rats, under the conditions of the G...

Immunoscore: A test to improve the care and treatment of colon cancer

(INSERM (Institut national de la santé et de la recherche médicale)) With Immunoscore, a test devised by a team of researchers from Inserm and Université Paris Descartes and doctors from the Paris ...

CLOVES Syndrome: Remarkable improvement in the health of 19 patients medical first

(INSERM (Institut national de la santé et de la recherche médicale)) Dr Guillaume Canaud at the Necker-Enfants Malades Hospital AP-HP, the Paris Descartes University, Inserm and his team recently d...

Seeing the Unexpected: Regulatory T Cells and Basophils

Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.

A protein that makes you do the twist

Asymmetry plays a major role in biology at every scale: think of DNA spirals, the fact that the human heart is positioned on the left, our preference to use our left or right hand ... A team from the...

A test to improve the care and treatment of colon cancer

Disease progression in patients with colon cancer can now be defined more accurately with Immunoscore, a test devised by a team of researchers from Inserm and Université Paris Descartes and doctors f...

Drugs and Medications [0 Results]


Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease

The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U8...

Nice Human Immunodeficiency Virus (HIV) Cohort

Historically, the database on the HIV was organized within the framework of the medico-economic file of the human immunodeficiency (DMI-2), introduced jointly by the Direction of Hospitals...

Search for New Genetic Mutations Major Effect in Crohn's Disease

This study highlight genetics mutations with major effect in Crohn's Disease (CD) by WES in individuals affected and healthy individuals from EPIMAD Inserm InVS registry families.

Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers

The aim of this study is to validate in the context of liver transplantation, the interest of the cccDNA assay technique developed by the team of Professor Zoulim (INSERM U1052) on liver b...

Searching Biomarkers of Acute Intestinal Ischemic Injuries

The aim of the SURVIBIO study is to characterize acurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based...

Companies [16 Associated Companies listed on BioPortfolio]

Acticor Biotech

Acticor Biotech is a clinical stage biotechnology company, spin-off of INSERM, dedicated to developing an innovative treatment in the therapy of acute thrombotic diseases, includi...

Annapurna Therapeutics and Weill Cornell Medicine

Annapurna Therapeutics, headquartered in Paris, is a privately held company dedicated to advancing gene therapy for significant unmet medical needs. It is funded by Versant Ventur...



TcLand S.A.

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmac...


Spun off from Inserm (the French institute of health and medical research) in 2009, Sensorion is a biotech that specializes in the treatment of pathologies of the inner ear such a...

More Information about "Inserm" on BioPortfolio

We have published hundreds of Inserm news stories on BioPortfolio along with dozens of Inserm Clinical Trials and PubMed Articles about Inserm for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inserm Companies in our database. You can also find out about relevant Inserm Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record